Thermo Fisher ( (TMO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Thermo Fisher Scientific’s stock has been positively influenced by its strategic acquisition of Clario Holdings for around $8.875 billion, which is anticipated to boost its clinical trial capabilities and immediately enhance earnings. Analysts have maintained or increased their price targets, supported by Thermo Fisher’s robust Q3 earnings, strategic growth plans, and favorable market conditions. Although there has been some insider selling suggesting negative sentiment, the overall outlook remains optimistic due to expected revenue synergies and the company’s solid market standing.
More about Thermo Fisher
YTD Price Performance: 7.62%
Average Trading Volume: 2,132,274
Technical Sentiment Signal: Strong Buy
Current Market Cap: $210.8B
For further insights into TMO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.